| scholarly article | Q13442814 |
| P50 | author | Lorenza Putignani | Q56934247 |
| Paola Bernaschi | Q115917037 | ||
| P2093 | author name string | Andrea Urbani | |
| Cristina Russo | |||
| Federica Del Chierico | |||
| Giorgio Federici | |||
| Livia Mancinelli | |||
| Barbara Lucignano | |||
| Donato Menichella | |||
| Laura Pansani | |||
| Luana Coltella | |||
| Manuela Onori | |||
| Marta Argentieri | |||
| Stefania Ranno | |||
| P2860 | cites work | Identification of clinically relevant yeast species by DNA sequence analysis of the D2 variable region of the 25-28S rRNA gene. | Q46017693 |
| Nosocomial Candidemia: An Ounce of Prevention Is Better Than a Pound of Cure | Q56935049 | ||
| Human infections due to Malassezia spp | Q24616438 | ||
| Epidemiology of invasive candidiasis: a persistent public health problem | Q29616758 | ||
| Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. | Q33210615 | ||
| Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR. | Q33284996 | ||
| Characterization of microorganisms by MALDI mass spectrometry | Q33412166 | ||
| Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates | Q33477230 | ||
| MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole | Q33502781 | ||
| Rapid species diagnosis for invasive candidiasis using mass spectrometry | Q33527403 | ||
| Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the [...] | Q33827176 | ||
| Towards a targeted, risk-based, antifungal strategy in neutropenic patients | Q34022479 | ||
| Invasive aspergillosis in 2002: an update | Q34603584 | ||
| Use of Fourier-transform infrared spectroscopy for typing of Candida albicans strains isolated in intensive care units | Q34774113 | ||
| Candida parapsilosis, an emerging fungal pathogen | Q34852747 | ||
| New approaches to the risk of Candida in the intensive care unit | Q35587111 | ||
| Rapid identification of Candida species by FT-IR microspectroscopy | Q36160471 | ||
| Changing face of health-care associated fungal infections | Q36178113 | ||
| Patients at high risk of invasive fungal infections: when and how to treat | Q37263189 | ||
| Clinical aspects of invasive candidiasis in paediatric patients | Q37624706 | ||
| Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy | Q37682908 | ||
| Experience with the MicroSeq D2 Large-Subunit Ribosomal DNA Sequencing Kit for Identification of Commonly Encountered, Clinically Important Yeast Species | Q40172952 | ||
| Microsatellite typing identifies the major clades of the human pathogen Candida albicans. | Q41434673 | ||
| Evaluation of new colorimetric vitek 2 yeast identification card by use of different source media | Q41851306 | ||
| Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. | Q44984663 | ||
| P433 | issue | 3 | |
| P921 | main subject | matrix-assisted laser desorption/ionization | Q736400 |
| P304 | page(s) | 620-629 | |
| P577 | publication date | 2010-10-21 | |
| P1433 | published in | Molecular BioSystems | Q3319467 |
| P1476 | title | MALDI-TOF mass spectrometry proteomic phenotyping of clinically relevant fungi | |
| P478 | volume | 7 |
| Q58762500 | A MALDI-TOF MS Approach for Mammalian, Human, and Formula Milks' Profiling |
| Q35764810 | A Simple and Effective Mass Spectrometric Approach to Identify the Adulteration of the Mediterranean Diet Component Extra-Virgin Olive Oil with Corn Oil |
| Q35222648 | A sensitive and effective proteomic approach to identify she-donkey's and goat's milk adulterations by MALDI-TOF MS fingerprinting. |
| Q33900027 | Accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinical pathogenic fungi: a meta-analysis |
| Q34667403 | Advancement in the routine identification of anaerobic bacteria by MALDI-TOF mass spectrometry. |
| Q35581632 | Analyses of black fungi by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS): species-level identification of clinical isolates of Exophiala dermatitidis |
| Q35268310 | Application of MALDI-TOF MS for requalification of a Candida clinical isolates culture collection |
| Q64281790 | Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia |
| Q34155689 | Comparison of the Microflex LT and Vitek MS systems for routine identification of bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry |
| Q34351558 | Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts |
| Q36362961 | Echinocandin resistance in two Candida haemulonii isolates from pediatric patients |
| Q42178239 | Effects of sub-lethal high-pressure homogenization treatment on the outermost cellular structures and the volatile-molecule profiles of two strains of probiotic lactobacilli |
| Q34015097 | Epidemiological analysis of worldwide bovine, canine and human clinical Prototheca isolates by PCR genotyping and MALDI-TOF mass spectrometry proteomic phenotyping |
| Q34306260 | Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals |
| Q34000455 | Evaluation of repetitive sequence PCR and PCR-mass spectrometry for the identification of clinically relevant Candida species |
| Q35718206 | Evaluation of the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Bruker Biotyper for identification of Penicillium marneffei, Paecilomyces species, Fusarium solani, Rhizopus species, and Pseudallescheria boydii |
| Q64067846 | Gut microbiota profile in children affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture |
| Q34111978 | MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review). |
| Q46253000 | MALDI-TOF-MS with PLS Modeling Enables Strain Typing of the Bacterial Plant Pathogen Xanthomonas axonopodis |
| Q34529370 | MALDI-TOF-MS-based species identification and typing approaches in medical mycology. |
| Q34180627 | Mass spectrometry in the clinical microbiology laboratory |
| Q34653849 | Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology |
| Q46247806 | Merging FT-IR and NGS for simultaneous phenotypic and genotypic identification of pathogenic Candida species. |
| Q34767125 | Microbial tracking of multidrug-resistant Klebsiella pneumoniae isolates in a pediatric hospital setting |
| Q34546734 | Non-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples. |
| Q41445317 | PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens |
| Q38014272 | Potential of MALDI-TOF mass spectrometry as a rapid detection technique in plant pathology: identification of plant-associated microorganisms. |
| Q47706902 | Pushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification |
| Q35024825 | Rapid identification and subtyping of Helicobacter cinaedi strains by intact-cell mass spectrometry profiling with the use of matrix-assisted laser desorption ionization-time of flight mass spectrometry |
| Q34122316 | The construction and evaluation of reference spectra for the identification of human pathogenic microorganisms by MALDI-TOF MS. |
| Q58786237 | Validation of a simplex PCR assay enabling reliable identification of clinically relevant Candida species |
Search more.